tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market
Advertisement

Tvardi Therapeutics (TVRD) Technical Analysis

Compare
2,485 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Tvardi Therapeutics’s (TVRD) Moving Averages Convergence Divergence (MACD) indicator is 1.42, suggesting Tvardi Therapeutics is a Sell.
Tvardi Therapeutics’s (TVRD) 20-Day exponential moving average is 28.09, while Tvardi Therapeutics’s (TVRD) share price is $31.11, making it a Buy.
Tvardi Therapeutics’s (TVRD) 50-Day exponential moving average is 26.50, while Tvardi Therapeutics’s (TVRD) share price is $31.11, making it a Buy.

Tvardi Therapeutics (TVRD) Pivot Points

Sep 07, 2025, 03:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.33
28.04
29.24
29.94
31.14
31.85
33.05
Fibonacci
28.04
28.77
29.22
29.94
30.67
31.12
31.85
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tvardi Therapeutics (TVRD) Moving Averages

Sep 07, 2025, 03:38 AM
Period
Simple
Exponential
MA5
29.96Buy
30.15Buy
MA10
29.71Buy
29.35Buy
MA20
27.16Buy
28.09Buy
MA50
25.74Buy
26.50Buy
MA100
25.48Buy
24.47Buy
MA200
19.72Buy
19.83Buy
Tvardi Therapeutics’s (TVRD) 10-Day exponential moving average is 29.35, while Tvardi Therapeutics’s (TVRD) share price is $31.11, making it a Buy.
Tvardi Therapeutics’s (TVRD) 100-Day exponential moving average is 24.47, while Tvardi Therapeutics’s (TVRD) share price is $31.11, making it a Buy.
Tvardi Therapeutics’s (TVRD) stock price is $31.11 and Tvardi Therapeutics’s (TVRD) 50-day simple moving average is 25.74, creating a Buy signal.
Tvardi Therapeutics’s (TVRD) stock price is $31.11 and Tvardi Therapeutics’s (TVRD) 100-day simple moving average is 25.48, creating a Buy signal.
Tvardi Therapeutics’s (TVRD) stock price is $31.11 and Tvardi Therapeutics’s (TVRD) 200-day simple moving average is 19.72, creating a Buy signal.

Tvardi Therapeutics (TVRD) Technical Indicators

Sep 07, 2025, 03:38 AM
Name
Value
Implied Action
RSI (14)
66.54
Neutral
STOCH (9,6)
71.08
Neutral
STOCHRSI (14)
81.39
Sell
MACD (12,26)
1.42
Sell
ADX (14)
31.58
Neutral
Williams %R
-9.52
Sell
CCI (14)
106.05
Sell
ATR (14)
1.84
-
Ultimate Oscillator
58.00
Neutral
ROC
29.62
Buy
Tvardi Therapeutics’s (TVRD) Relative Strength Index (RSI) is 66.54, creating a Neutral signal.
Tvardi Therapeutics’s (TVRD) Trend Strength Indicator (ADX) is 31.58, creating a Neutral signal.
Tvardi Therapeutics’s (TVRD) Commodity Channel Index (CCI) is 106.05, creating a Sell signal.
Tvardi Therapeutics’s (TVRD) Price Rate of Change (ROC) is 29.62, creating a Buy signal.

FAQ

Is TVRD a Buy, Hold, or Sell?
Based on TVRD’s technical indicators, TVRD is a Buy.
    What is TVRD’s RSI (14)?
    TVRD’s RSI (14) is 66.54, which suggests TVRD is a Neutral.
      What is TVRD’s MACD?
      TVRD’s MACD is 1.42, which suggests TVRD is a Sell.
        What is TVRD’s 5-day moving average?
        TVRD’s 5-day moving average is 29.96, which suggests TVRD is a Buy.
          What is TVRD’s 20-day moving average?
          TVRD 20-day moving average is 27.16, which suggests TVRD is a Buy.
            What is TVRD’s 50-day moving average?
            TVRD’s 50-day moving average is 25.74, which suggests TVRD is a Buy.
              What is TVRD’s 200-day moving average?
              TVRD’s 200-day moving average is 19.72, which suggests TVRD is a Buy.
                What is TVRD’s Williams % R (14)?
                TVRD’s Williams % R (14) is -9.52, which suggests TVRD is a Sell.
                  What is TVRD’s CCI (14)?
                  TVRD’s CCI (14) is 106.05, which suggests TVRD is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis